Your Browser Is No Longer Supported. Please upgrade your browser from Internet Explorer 10 to Internet Explorer 11 or higher
SHM joined a multi-stakeholder letter supporting the "Resident Physician Shortage Reduction Act." This legislation will expand the physician workforce by gradually raising the number of
SHM joined a multi-stakeholder letter to CMS regarding proposals related to the Merit-based Incentive Payment System (MIPS) Value Pathway (MVP) proposals. Specifically, the letter urges CMS to
SHM sent a letter strongly supporting the confirmation of Vivek Murthy as the Surgeon General.
SHM supports the reintroduction of the Mainstreaming Addiction Treatment Act. This legislation will eliminate the X-Waiver prescribing requirement for buprenorphine, a lifesaving medication used
CMS has finalized E/M payment adjustments that will lead to an approximate 8% decrease in Medicare Fee for Service Revenue for hospitalists. Learn more about the issue--and about how SHM is
The Department of Health and Human Services (HHS) has expanded access to buprenorphine, a life-saving treatment for opioid use disorder.
SHM and other stakeholders sent a letter to Congressional leaders, urging for the elimination of the X-waiver. Eliminating the X-waiver will expand access to buprenorphine, a lifesaving treatment
SHM, ACEP, AMDA, IDSA and SCCM send joint letter to Congressional Leaders to urge relief from upcoming reimbursement reductions in the 2021 Medicare Physician Fee Schedule.
SHM joins the American College of Physicians (ACP) and other subspecialties in expressing our concern over the upcoming compliance deadlines included in the "Patient Access" rule.
In light of recent comments disregarding the legitimacy and training of osteopathic physicians, SHM joined the CMSS statement support of osteopathic physicians.